Joseph Giuliano

Joseph Giuliano is a medical affairs professional with over 30 years of experience in the pharmaceutical and healthcare industry. He is currently the Vice President of US and Global Medical Affairs at Amicus Therapeutics in Princeton, New Jersey.1

In his current role, Giuliano led the major medical launch of the first new medicine for Fabry disease in 15 years. He is responsible for global medical strategy, publications, evidence generation planning, and disease registry strategy.1

Giuliano's career includes significant positions at various companies:

• Amicus Therapeutics (2016-present): Progressed from Global Medical Lead for Fabry Disease to his current VP role1
• CHDI Foundation (2008-2016): Director of Clinical and Medical Operations1
• GE Healthcare (2003-2008): Associate Director of Clinical Operations1
• The Johns Hopkins University School of Medicine (1996-1998): Senior Research Nurse/Program Coordinator in Neurology1

He holds a B.S. in Nursing and an AB in Chemistry from The Catholic University of America.1 Giuliano is also certified as a Six Sigma Green Belt and Lean Six Sigma Green Belt from GE Healthcare.1